Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Cryoport management to meet with B. Riley » 04:55
05/27/22
05/27
04:55
05/27/22
04:55
CYRX

Cryoport

$23.08 /

+0.92 (+4.15%)

B. Riley hosts a site…

B. Riley hosts a site visit to the company's Global Logistics Centers in Irvine, CA on May 27.

ShowHide Related Items >><<
CYRX Cryoport
$23.08 /

+0.92 (+4.15%)

CYRX Cryoport
$23.08 /

+0.92 (+4.15%)

05/17/22 B. Riley
Cryoport price target lowered to $55 from $61 at B. Riley
05/06/22 BTIG
Cryoport price target lowered to $60 from $95 at BTIG
05/06/22 KeyBanc
Cryoport price target lowered to $52 from $92 at KeyBanc
05/05/22 B. Riley
B. Riley cuts Cryoport target but says shares oversold
CYRX Cryoport
$23.08 /

+0.92 (+4.15%)

Conference/Events
Cryoport management to meet with B. Riley » 08:40
05/24/22
05/24
08:40
05/24/22
08:40
CYRX

Cryoport

$23.39 /

+0.14 (+0.60%)

B. Riley hosts a site…

B. Riley hosts a site visit to the company's Global Logistics Centers in Irvine, CA on May 27.

ShowHide Related Items >><<
CYRX Cryoport
$23.39 /

+0.14 (+0.60%)

CYRX Cryoport
$23.39 /

+0.14 (+0.60%)

05/17/22 B. Riley
Cryoport price target lowered to $55 from $61 at B. Riley
05/06/22 BTIG
Cryoport price target lowered to $60 from $95 at BTIG
05/06/22 KeyBanc
Cryoport price target lowered to $52 from $92 at KeyBanc
05/05/22 B. Riley
B. Riley cuts Cryoport target but says shares oversold
CYRX Cryoport
$23.39 /

+0.14 (+0.60%)

Recommendations
Cryoport price target lowered to $55 from $61 at B. Riley » 07:42
05/17/22
05/17
07:42
05/17/22
07:42
CYRX

Cryoport

$23.65 /

-0.83 (-3.39%)

B. Riley analyst Yuan Zhi…

B. Riley analyst Yuan Zhi lowered the firm's price target on Cryoport to $55 from $61 and keeps a Buy rating on the shares. The recent stock movement in the healthcare service an technology sector and the trading volume in the past week gives confidence in the "bottom-forming of these growth-oriented stocks," Zhi tells investors in a research note. The analyst remains a buyer of the life sciences services providers that maintain "strong growth."

ShowHide Related Items >><<
CYRX Cryoport
$23.65 /

-0.83 (-3.39%)

CYRX Cryoport
$23.65 /

-0.83 (-3.39%)

05/06/22 BTIG
Cryoport price target lowered to $60 from $95 at BTIG
05/06/22 KeyBanc
Cryoport price target lowered to $52 from $92 at KeyBanc
05/05/22 B. Riley
B. Riley cuts Cryoport target but says shares oversold
05/03/22 Roth Capital
Cryoport price target lowered to $67 from $90 at Roth Capital
CYRX Cryoport
$23.65 /

-0.83 (-3.39%)

Recommendations
Cryoport price target lowered to $60 from $95 at BTIG » 09:33
05/06/22
05/06
09:33
05/06/22
09:33
CYRX

Cryoport

$24.14 /

-1.83 (-7.05%)

BTIG analyst David Larsen…

BTIG analyst David Larsen lowered the firm's price target on Cryoport to $60 from $95 but keeps a Buy rating on the shares. The company's Q1 results were "surprisingly good" given his concerns around supply chain headwinds, inflation, and the overall environment, though his reduced price target reflects the broader market pullback, the analyst tells investors in a research note.

ShowHide Related Items >><<
CYRX Cryoport
$24.14 /

-1.83 (-7.05%)

CYRX Cryoport
$24.14 /

-1.83 (-7.05%)

05/06/22 KeyBanc
Cryoport price target lowered to $52 from $92 at KeyBanc
05/05/22 B. Riley
B. Riley cuts Cryoport target but says shares oversold
05/03/22 Roth Capital
Cryoport price target lowered to $67 from $90 at Roth Capital
03/02/22 B. Riley
Cryoport price target lowered to $70 from $94 at B. Riley
CYRX Cryoport
$24.14 /

-1.83 (-7.05%)

Recommendations
Cryoport price target lowered to $52 from $92 at KeyBanc » 07:53
05/06/22
05/06
07:53
05/06/22
07:53
CYRX

Cryoport

$24.14 /

-1.83 (-7.05%)

KeyBanc analyst Paul…

KeyBanc analyst Paul Knight lowered the firm's price target on Cryoport to $52 from $92 and keeps an Overweight rating on the shares. Cryoport reported a top-line beat, but the growth in cell therapy markets was evident with 56% growth in approved therapy logistic revenue, Knight tells investors in a research note. The analyst expects acceleration in Cryoport's core logistics business with the recent FDA approval for capacity expansion at Kite's production site for Yescarta.

ShowHide Related Items >><<
CYRX Cryoport
$24.14 /

-1.83 (-7.05%)

CYRX Cryoport
$24.14 /

-1.83 (-7.05%)

05/05/22 B. Riley
B. Riley cuts Cryoport target but says shares oversold
05/03/22 Roth Capital
Cryoport price target lowered to $67 from $90 at Roth Capital
03/02/22 B. Riley
Cryoport price target lowered to $70 from $94 at B. Riley
02/25/22 SVB Securities
Cryoport price target lowered to $75 from $92 at SVB Leerink
CYRX Cryoport
$24.14 /

-1.83 (-7.05%)

Earnings
Cryoport Sees 2022 revenue $260M-$265M, consensus $257.32M » 17:00
05/05/22
05/05
17:00
05/05/22
17:00
CYRX

Cryoport

$24.14 /

-1.83 (-7.05%)

2022 revenue guidance…

2022 revenue guidance represents an increase of approximately 17% to 19% over 2021 revenue. The company expects that revenue will primarily be driven by the record backlog for cryogenic freezer and shipper systems and solutions, growth from support of clinical trials and commercially launched therapies from cell the gene therapy clients, growth in temperature-controlled logistics and transport and the expanded client utilization of its new and expanding biostorage services.

ShowHide Related Items >><<
CYRX Cryoport
$24.14 /

-1.83 (-7.05%)

CYRX Cryoport
$24.14 /

-1.83 (-7.05%)

05/05/22 B. Riley
B. Riley cuts Cryoport target but says shares oversold
05/03/22 Roth Capital
Cryoport price target lowered to $67 from $90 at Roth Capital
03/02/22 B. Riley
Cryoport price target lowered to $70 from $94 at B. Riley
02/25/22 SVB Securities
Cryoport price target lowered to $75 from $92 at SVB Leerink
CYRX Cryoport
$24.14 /

-1.83 (-7.05%)

Earnings
Cryoport reports Q1 EPS (31c), consensus (22c) » 16:59
05/05/22
05/05
16:59
05/05/22
16:59
CYRX

Cryoport

$24.14 /

-1.83 (-7.05%)

Reports Q1 revenue…

Reports Q1 revenue $52.3M, consensus $52.86M. CEO Jerrell Shelton commented, "Overall, our businesses performed well in the first quarter although revenue was adversely impacted by approximately $9.4M from the previously disclosed fire at our New Prague, MN manufacturing plant. We believe the impact was isolated to the first quarter of 2022 and we intend to recapture the revenue throughout the remainder of 2022...Biopharma/Pharma revenue was $43.0M for Q1 vs. $42.4M for 1Q21. Revenue from commercial therapies for the quarter grew 53.5% to a record $3.9M and we grew our overall pipeline of business...We closed the first quarter with approximately $600M in cash and cash equivalents and short-term investments, strengthened our position in the high growth APAC and EMEA regions through the acquisition of Cell&Co BioServices in France, and continue to rapidly expand our footprint and services with the grand openings of the first two of our new Global Supply Chain Centers next month, which is the beginning of our new Global Supply Chain Center Network, to include comprehensive Good Manufacturing Practice Bioservices...Our outlook for the remainder of the year is solid. We expect full year revenue for 2022 to be between $260M-$265M, representing a 17% to 19% increase over 2021 revenue."

ShowHide Related Items >><<
CYRX Cryoport
$24.14 /

-1.83 (-7.05%)

CYRX Cryoport
$24.14 /

-1.83 (-7.05%)

05/05/22 B. Riley
B. Riley cuts Cryoport target but says shares oversold
05/03/22 Roth Capital
Cryoport price target lowered to $67 from $90 at Roth Capital
03/02/22 B. Riley
Cryoport price target lowered to $70 from $94 at B. Riley
02/25/22 SVB Securities
Cryoport price target lowered to $75 from $92 at SVB Leerink
CYRX Cryoport
$24.14 /

-1.83 (-7.05%)

Recommendations
B. Riley cuts Cryoport target but says shares oversold » 08:08
05/05/22
05/05
08:08
05/05/22
08:08
CYRX

Cryoport

$25.97 /

+1.38 (+5.61%)

B. Riley analyst Yuan Zhi…

B. Riley analyst Yuan Zhi lowered the firm's price target on Cryoport to $61 from $70 and keeps a Buy rating on the shares. The analyst views the shares as oversold and says the recent stock movement "indicates a good sign of bottom formation." Zhi dropped the price target to reflect the one-time impact from fire damage and the latest tuck-in acquisition.

ShowHide Related Items >><<
CYRX Cryoport
$25.97 /

+1.38 (+5.61%)

CYRX Cryoport
$25.97 /

+1.38 (+5.61%)

05/03/22 Roth Capital
Cryoport price target lowered to $67 from $90 at Roth Capital
03/02/22 B. Riley
Cryoport price target lowered to $70 from $94 at B. Riley
02/25/22 SVB Securities
Cryoport price target lowered to $75 from $92 at SVB Leerink
01/19/22 Roth Capital
Roth Capital upgrades Cryoport to Buy with $90 price target
CYRX Cryoport
$25.97 /

+1.38 (+5.61%)

Recommendations
Cryoport price target lowered to $67 from $90 at Roth Capital » 08:43
05/03/22
05/03
08:43
05/03/22
08:43
CYRX

Cryoport

$23.38 /

+0.93 (+4.14%)

Roth Capital analyst…

Roth Capital analyst Richard Baldry lowered the firm's price target on Cryoport to $67 from $90 to reflect broad sector valuation weakness, while keeping a Buy rating on the shares. The analyst notes that a fire in a manufacturing facility will lower Q1 revenues by $9.0M-$9.5M. However, Cryoport expects the majority of associated costs and losses to be covered by insurance. With its facility again operational, Baldry expects delayed revenues to be made up over the balance of 2022 and therefore his full year model is more back-end loaded, but not cut.

ShowHide Related Items >><<
CYRX Cryoport
$23.38 /

+0.93 (+4.14%)

CYRX Cryoport
$23.38 /

+0.93 (+4.14%)

03/02/22 B. Riley
Cryoport price target lowered to $70 from $94 at B. Riley
02/25/22 SVB Securities
Cryoport price target lowered to $75 from $92 at SVB Leerink
01/19/22 Roth Capital
Roth Capital upgrades Cryoport to Buy with $90 price target
01/19/22 Roth Capital
Cryoport upgraded to Buy from Neutral at Roth Capital
CYRX Cryoport
$23.38 /

+0.93 (+4.14%)

Hot Stocks
Cryoport acquires Cell&Co BioServices for EUR6.2M » 08:32
04/18/22
04/18
08:32
04/18/22
08:32
CYRX

Cryoport

$29.75 /

-1.6 (-5.10%)

Cryoport announced that…

Cryoport announced that it has acquired Cell&Co BioServices, headquartered in Clermont-Ferrand, France with additional operations in Pont-du-Chateau, France. Founded in 2012, Cell&Co is a bioservices business providing biorepository, kitting, and logistics services to the life sciences industry. Its accreditations include ISO 9001, ANSM, NFS 96 900, and soon, ISO 20387. Supporting its biostorage and services of clinical and commercial biopharma therapies, Cell&Co has in-house QP services. In 2021, Cell&Co recorded revenue of approximately EUR2.6M. Cryoport's purchase price for Cell&Co was EUR6.2M, comprised of upfront consideration of EUR3.6M in the form of cash and Cryoport common stock, plus a potential earn-out of EUR2.5M based on achieving certain financial targets.

ShowHide Related Items >><<
CYRX Cryoport
$29.75 /

-1.6 (-5.10%)

CYRX Cryoport
$29.75 /

-1.6 (-5.10%)

03/02/22 B. Riley
Cryoport price target lowered to $70 from $94 at B. Riley
02/25/22 SVB Securities
Cryoport price target lowered to $75 from $92 at SVB Leerink
01/19/22 Roth Capital
Roth Capital upgrades Cryoport to Buy with $90 price target
01/19/22 Roth Capital
Cryoport upgraded to Buy from Neutral at Roth Capital
CYRX Cryoport
$29.75 /

-1.6 (-5.10%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.